Navigation Links
Bush vetoes stem cell research bill

Washington, D.C. - Calling the destruction of human embryos a line that society should not cross, President Bush has vetoed a bill that would have overturned his ban on new federal funding for human embryonic stem cell research, and an override attempt failed in the House of Representatives.

"It crosses a moral boundary that our decent......

Full article >>> le blasts veto

Following the veto, Wisconsin Gov. Jim Doyle held a conference call with state reporters. Doyle said he looked forward to the day when there will be a different president who would support additional federal funding for human embryonic stem cell research.

Doyle, appearing with Custer, Wis. resident Pam Fleishauer, wh......

Full article >>> lative affairs director. "President Bush stood tall today in the preservation of human life."

Earlier, Sande had blasted Wisconsin Senators Herb Kohl and Russ Feingold, who voted for H.R. 810.

In the House vote, the Wisconsin delegation was split along partisan lines. Voting to override the veto were Democrats Tammy Baldwin, Ron Kind, Gwen Moore, and David Obey. Joining Green in......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 07/19/06


Related biology technology :

1. Doyle vetoes cloning ban
2. Doyle partially vetoes SE Wisconsin technology grant
3. Separating hope from hype in stem-cell research
4. NimbleGen researcher to lead $415K DNA project
5. UW-Madison to receive $125M for bioenergy research center
6. Jamie Thomson to run California research lab
7. Mirus Bio secures $900K grant to develop research tool
8. UW-Madison launches new high-speed research network
9. Of private equity, research, and drug development
10. Wisconsin can offer what a federal energy research lab needs
11. UW-Madison approves new research institute
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... , ... February 24, 2017 , ... Delpor, Inc. (Delpor), ... grant from the National Institute of Mental Health (NIMH) for the further advancement of ... PROZOR technology and is expected to deliver therapeutic levels of olanzapine for ...
(Date:2/24/2017)... FRANCISCO , Feb. 24, 2017 Symic ... is developing a new category of therapeutics, announced today ... of SB-030 in peripheral artery disease. The trial will ... administered single-use therapeutic, in the reduction of restenosis following ... this critical development milestone for SB-030," said Nathan ...
(Date:2/24/2017)... Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: ... plasma-based biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2016 Financial Highlights ... by 21.7% in RMB terms, or increased by 13.6% in ... same quarter of 2015. Gross profit increased ...
(Date:2/23/2017)... Feb. 23, 2017 ... except per share data, unaudited)Three Months Ended December 31,Twelve ... Revenue $       ... 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  756025%297303(2)%Vimizim ...
Breaking Biology Technology:
(Date:2/26/2017)... 25, 2017  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announces the ... "Too often, too many offenders return ... jails are trying to tackle this ongoing problem ... and family members. While significant steps are underway, Securus ...
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
Breaking Biology News(10 mins):